G1 Therapeutics, Inc. Profile Avatar - Palmy Investing

G1 Therapeutics, Inc.

G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease c…

Biotechnology
US, Research Triangle Park [HQ]

Government Awards Analysis Beta

Obligations Over-Time

Awards
Obligations

G1 Therapeutics, Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0
vs. Previous FY
Contracts
$ 0.0
IDVs
$ 0.0
Direct Payments
$ 0.0
Grants
$ 0.0
Loans
$ 0.0
Other Payments
$ 0.0

Spending By Type

Awards
Obligations

G1 Therapeutics, Inc. can't present spending by time.

Get PRO Today

With PRO you will unlock all insights related to government awards of G1 Therapeutics, Inc..

End of GTHX's Analysis
CIK: 1560241 CUSIP: 3621LQ109 ISIN: US3621LQ1099 LEI: - UEI: -
Secondary Listings
GTHX has no secondary listings inside our databases.